Posted on April 1st, 2010 by Health News
Reacting to the news that tamsulosin, for men’s urinary problems - previously only available on prescription - is now available through pharmacies, Graham Phillips, pharmacist, and Royal Pharmaceutical Society English Pharmacy Board Member said: “Racks of make-up and no spanners” 1 was the title of a report published by the Men’s Health Forum in [...]
No Comments »
Filed under: Men's Health
Posted on April 1st, 2010 by Health News
The inaugural “Gender, Bodies, and Technology” conference has attracted scholars from 10 countries in disciplines from the humanities, social and natural sciences, visual and performing arts, engineering, and technology. The conference will take place at Hotel Roanoke in Roanoke, Va., April 22-24…
No Comments »
Filed under: Women's Health
Posted on April 1st, 2010 by Health News
Following a two-day meeting of foreign ministers from G8 countries in Quebec on Tuesday, Secretary of State Hillary Rodham Clinton “appeared at odds …
No Comments »
Filed under: Women's Health
Posted on April 1st, 2010 by Health News
Many older adults have completed advance directives by the time they’re needed, and they work (MedPage Today) — ensuring care patients would have wanted, according to family members.
No Comments »
Filed under: General Health News
Posted on April 1st, 2010 by Health News
Medicaid patient visits to the emergency department are on the rise nationwide in contrast to overall trends in emergency visits, according to a market analysis firm.
No Comments »
Filed under: General Health News
Posted on April 1st, 2010 by Health News
Among life sciences researchers, women still earn less than their male counterparts, with no obvious explanation, researchers found.
No Comments »
Filed under: General Health News
Posted on April 1st, 2010 by Health News
WASHINGTON (MedPage Today) — The FDA has approved the injectable varicose vein treatment polidocanol (Asclera).
No Comments »
Filed under: Pharmacy News
Posted on April 1st, 2010 by Health News
Symphogen A/S today announced that it has initiated a Phase 1/2 human clinical trial in the US to evaluate the safety, tolerability and efficacy of its drug candidate Sym004 for the treatment of advanced solid tumors. Sym004 is composed of two anti-epidermal growth factor receptor monoclonal antibodies targeting different nonoverlapping EGFR epitopes.
No Comments »
Filed under: Pharmacy News
Posted on April 1st, 2010 by Health News
Repros Therapeutics Inc. today announced that the Company is sending a reply to the FDA’s Division of Metabolism and Endocrinology Products following the Company’s receipt of FDA’s comments on the proposed Phase II study of Androxal® (enclomiphene) in the treatment of Type II diabetes under Repros’ open IND. On February 2, 2010 the Company announced [...]
No Comments »
Filed under: Pharmacy News
Posted on April 1st, 2010 by Health News
Omeros Corporation today announced that a Phase 2 clinical trial of OMS103HP, its PharmacoSurgery™ product candidate for arthroscopy, demonstrated that patients treated with OMS103HP during arthroscopic knee meniscectomy surgery achieved statistically significant clinical benefits.
No Comments »
Filed under: Pharmacy News
